Maja G. Erke

Increasing Prevalence of Myopia in Europe and the Impact of Education

Purpose To investigate whether myopia is becoming more common across Europe and explore whether increasing education levels, an important environmental risk factor for myopia, might explain any temporal trend. Design Meta-analysis of population-based, cross-sectional studies from the European Eye Epidemiology (E3) Consortium. Participants The E3 Consortium is a collaborative network of epidemiological studies of common eye diseases in adults across Europe. Refractive data were available for 61 946 participants from 15 population-based studies performed between 1990 and 2013; participants had a range of median ages from 44 to 78 years. Methods Noncycloplegic refraction, year of birth, and highest educational level achieved were obtained for all participants. Myopia was defined as a mean spherical equivalent ≤−0.75 diopters. A random-effects meta-analysis of age-specific myopia prevalence was performed, with sequential analyses stratified by year of birth and highest level of educational attainment. Main Outcome Measures Variation in age-specific myopia prevalence for differing years of birth and educational level. Results There was a significant cohort effect for increasing myopia prevalence across more recent birth decades; age-standardized myopia prevalence increased from 17.8% (95% confidence interval [CI], 17.6–18.1) to 23.5% (95% CI, 23.2–23.7) in those born between 1910 and 1939 compared with 1940 and 1979 (P = 0.03). Education was significantly associated with myopia; for those completing primary, secondary, and higher education, the age-standardized prevalences were 25.4% (CI, 25.0–25.8), 29.1% (CI, 28.8–29.5), and 36.6% (CI, 36.1–37.2), respectively. Although more recent birth cohorts were more educated, this did not fully explain the cohort effect. Compared with the reference risk of participants born in the 1920s with only primary education, higher education or being born in the 1960s doubled the myopia prevalence ratio–2.43 (CI, 1.26–4.17) and 2.62 (CI, 1.31–5.00), respectively—whereas individuals born in the 1960s and completing higher education had approximately 4 times the reference risk: a prevalence ratio of 3.76 (CI, 2.21–6.57). Conclusions Myopia is becoming more common in Europe; although education levels have increased and are associated with myopia, higher education seems to be an additive rather than explanatory factor. Increasing levels of myopia carry significant clinical and economic implications, with more people at risk of the sight-threatening complications associated with high myopia.

Prevalence of Age-related Macular Degeneration in Elderly Caucasians: The Tromsø Eye Study

PURPOSE To describe the sex- and age-specific prevalence of drusen, geographic atrophy, and neovascular age-related macular degeneration (AMD). DESIGN Population-based, cross-sectional study. PARTICIPANTS Caucasian adults aged 65 to 87 years from the 6th Tromsø Study, a population-based study conducted in 2007-2008 in the municipality of Tromsø, Norway. METHODS Digital color fundus photographs were graded for predominant phenotype based on drusen size, geographic atrophy, and neovascular AMD. MAIN OUTCOME MEASURES Age-related macular degeneration. RESULTS A total of 3025 subjects participated; 89% of those were invited to the eye examinations. Gradable photographs were available for 2631 persons (mean age 72.3 years). Drusen 63-125 μm as the predominant phenotype were found in 34.9% of participants (95% confidence interval [CI], 33.1-36.8), drusen >125 μm were found in 24.1% (95% CI, 22.5-25.8), geographic atrophy was found in 1.0% of participants (95% CI, 0.6-1.4), and neovascular AMD was found in 2.5% of participants (95% CI, 1.9-3.1). Bilateral involvement of late AMD was present in 1.1% of the sample. Eyes with late AMD had a significantly lower refractive error (spherical equivalent 0.078 vs. 0.99 diopters, P<0.0001), and 42.5% of eyes had Snellen visual acuity ≤ 0.32. CONCLUSIONS The prevalence of AMD among the elderly persons in this study was similar to rates in other Caucasian populations. Late AMD was present in 10.9% of subjects aged 80 years or more. No sex differences in prevalence rates of large drusen or late AMD were observed. Lower refractive error was observed in eyes with late AMD than in eyes without late AMD.

Cardiovascular risk factors associated with age-related macular degeneration: the Tromso Study

To examine associations between cardiovascular risk factors and age‐related macular degeneration (AMD).

Projected prevalence of age-related macular degeneration in Scandinavia 2012–2040

Purpose:  To project the number of persons with late age‐related macular degeneration (AMD) in Scandinavia through 2040.

The Tromsø Eye Study: study design, methodology and results on visual acuity and refractive errors

Purpose:  To describe the study design and methodology of the Tromsø Eye Study (TES), and to describe visual acuity and refractive error in the study population.

Cognitive function, drusen, and age-related macular degeneration: a cross-sectional study.

PurposeTo examine the cross-sectional relationship between drusen, late age-related macular degeneration (AMD), and cognitive function.MethodsWe included 2149 stroke-free participants from the population-based Tromsø Study in Norway. Retinal photographs were graded for presence of drusen and AMD. Cognitive function was assessed using the verbal memory test (short verbal memory), digit-symbol coding test (processing speed), and the tapping test (psychomotor tempo). We assessed the relationship between drusen, late AMD, and cognitive test scores, adjusted for potential confounders.ResultsLate AMD was associated with decreased performance in the verbal memory test (standardized β=−0.23, 95% confidence interval (CI): −0.51 to −0.01). Intermediate and large drusen were associated with decreased performance in the digit-symbol coding test (standardized β=−0.14 and –0.19, 95% CIs: −0.23 to −0.05 and −0.29 to −0.09, respectively). Participants with large drusen were more likely to have test scores in the lowest quartile of the digit-symbol coding test (odds ratio (OR)=1.9, 95% CI: 1.1–3.5) and the tapping test (OR=1.6, 95% CI: 1.0–2.6), but not in the verbal memory test (OR=1.0, 95% CI: 0.6–1.6).ConclusionsThe findings suggest a relationship between drusen deposition and reduced cognitive function. Although the relationships between drusen, late AMD, and the cognitive test results varied in strength and significance across the types of cognitive test, and may partly have been caused by residual confounding, it is not unlikely that a genuine but weaker relationship exists between drusen deposition and cognitive decline.

Lactation, female hormones and age-related macular degeneration: the Tromsø Study

Objective Some risk factors for age-related macular degeneration (AMD) have been shown to act differently in women and men. The present study aims to investigate this disparity by examining associations between female hormones, reproductive history and AMD. Methods Women aged 65–87 years were invited to this cross-sectional, population-based study in Norway. Participants underwent physical examination, retinal photography, answered questionnaires and had blood samples taken. Results The sample included 1512 women, of whom 48 (3.2%) had late AMD and 378 (25%) had large drusen >125 μm phenotype. Length of breast feeding per child was significantly associated with late AMD (OR per month 0.80, 95% CI 0.68 to 0.94) in multivariable regression analysis. We observed no associations between late AMD or drusen >125 μm and contraceptives, oral hormonal replacement therapy, parity, age at first childbirth, age of menarche, age of menopause, number of menstruating years or the reason for menopause. Conclusions Longer duration of lactation was associated with lower frequency of maternal late AMD when controlled for confounders. Other reproductive factors and hormone replacement therapy were not significantly associated with AMD.

Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration

The purpose was to review all patients with non-seminomatous germ cell tumours (NSGCT) treated at a single institution in order to evaluate the management and outcome. Patients were prospectively registered. Completed SWENOTECA forms and medical records of all 132 NSGCT patients treated between January 1985 and December 2000 were reviewed. Data on demographic, clinical, histological and biochemical characteristics as well as patient treatment and outcome were registered. The minimum follow-up was 2.2 years (median 8.3 years). In stage I, there was an overall relapse rate of 21%. These relapses were all treated successfully. Among stage II–IV patients, post treatment RPLND/surgical resections were performed in 31 patients (50%), and residual malignant disease was found in 23%. Relapse (N = 3) in metastatic disease patients, were seen in stage IV only. In stage II–IV, 5 died from germ cell malignancy of whom 3 never achieved CR. Five-year overall and disease-specific survivals were 95% and 96%. For stage I, II, III, and IV, the 5-year disease-specific survivals were 100%, 98%, 100%, and 69% respectively. Grouped according to the International Germ Cell Consensus Classification, the 5-year overall survivals were 100%, 92%, and 60% for the good, intermediate, and poor prognosis groups of stage II–IV patients, respectively. This report is a complete review of NSGCT patients treated in our minor university clinic. Survival rates are comparable to recently published data, due to a commitment to multicentre protocol and research collaboration.